Obesity and insulin resistance increase plasma viscosity in young women with polycystic ovary syndrome

References

• Urbanek M, Du Y, Silander K, Collins F S, Steppan C M, Strauss J F, 3rd, Dunaif A, Spielman R S, Legro R S. Variation in resistin gene promoter not associated with polycystic ovary syndrome. Diabetes 2003; 52: 214–217
   PubMed Web of Science ®Google Scholar
• Norman R J, Dewailly D, Legro R S, Hickey T E. Polycystic ovary syndrome. Lancet 2007; 25: 685–697
   Google Scholar
• Acien P, Quereda F, Matallin P, Villarroya E, Lopez-Fernandez J A, Acien M, Mauri M, Alfayate R. Insulin, androgens and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil Steril 1999; 72: 32–40
   PubMed Web of Science ®Google Scholar
• Perez-Martin A, Dumortier M, Pierrisnard E, Raynaud E, Mercier J, Brun J F. Multivariate analysis of relationships between insulin sensitivity and blood rheology: is plasma viscosity a marker of insulin resistance. Clin Hemorheol Micro-Circ 2001; 25: 91–103
   PubMed Web of Science ®Google Scholar
• Schnyder B, Pittet M, Durand J, Schnyder-Candrian S. Rapid effects of glucose on the insulin signalling of endothelial NO generation and epithelial Na transport. Am J Physiol Endocrinol Metab 2002; 282: E87–E94
   Google Scholar
• Arcaro G, Cretti A, Balzano S, Lechi A, Muggeo M, Bonora E, Bonadonna R C. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002; 105: 576–582
   PubMed Web of Science ®Google Scholar
• Wild R A. Polycystic ovary syndrome: a risk for coronary artery disease. Am J Obstet Gynecol 2002; 186: 35–43
   PubMed Web of Science ®Google Scholar
• Talbott E O, Zborowski J V, Sutton-Tyrell K, McHugh-Pemu K P, Guzick D S. Cardiovascular risk in women with polycystic ovary syndrome. Obstet Gynecol Clin North Am 2001; 281: 111–133
   Google Scholar
• Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni G E, Filicori M, Morselli-Labate A M. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without PCOS. J Clin Endocrinol Metab 2000; 85: 2767–2774
   PubMed Web of Science ®Google Scholar
• Patterson W, Caldwell C, Doll D. Hyperviscosity syndromes and coagulopathies. Semin Oncol 1990; 17: 210–216
   Google Scholar
• Balestri M, Ferrari F, Magistroni R, Mariano M, et al. Plasma exchange in acute and chronic hyperviscosity syndrome: a rheological approach and guidelines study. Ann Ist Super Sanita 2007; 43: 171–175
   Google Scholar
• Lowe G DO. Blood rheology in general medicine and surgery. Baillieres Clin Haematol 1987; 1: 827–862
   PubMedGoogle Scholar
• Mchedlishvili G. Disturbed blood flow structuring as critical factor of hemorheological disorders in microcirculation. Clin Hemorheol Microcirc 1998; 19: 315–325
   PubMed Web of Science ®Google Scholar
• Seplowitz A H, Chien S, Smith F R. Effects of lipoproteins on plasma viscosity. Atherosclerosis 1981; 38: 89–95
   PubMedGoogle Scholar
• Rosenson R S, Shott S, Tangney C C. Hypertriglyceridemia is associated with an elevated blood viscosity. Atherosclerosis 2002; 161: 433–439
   PubMed Web of Science ®Google Scholar
• Koenig W, Sund M, Filipiak B, Döring A, Löwel H, Ernst E. Plasma viscosity and the risk of coronary heart disease: results from the MONICA-Augsburg Cohort Study, 1984 to 1992. Arterioscler Thromb Vasc Biol 1998; 18: 768–772
   PubMed Web of Science ®Google Scholar
• Koenig W, Sund M, Löwel H, Döring A, Ernst E. Association between plasma viscosity and all-cause mortality: results from the MONICA-Augsburg Cohort Study 1984-92. Br J Haematol 2000; 109: 453–458
   PubMed Web of Science ®Google Scholar
• Coata G, Ventura F, Lombardini R, Ciuffetti G, Cosmi E V, Di Renzo G C. Effect of low-dose oral triphasic contraceptives on blood viscosity, coagulation and lipid metabolism. Contraception 1995; 52: 151–157
   Google Scholar
• Yarnell J W, Baker I A, Sweetnam P M, Bainton D, O'Brien J R, Whitehead P J, Elwood P C. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991; 83: 836–844
   Google Scholar
• Lowe G, Rumley A, Norrie J, Ford I, Shepherd J, Cobbe S, Macfarlane P, Packard C. Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study. Thromb Haemost 2000; 84: 553–558
   PubMed Web of Science ®Google Scholar
• Woodward M, Lowe G DO, Rumley A, Tunstall-Pedoe H, Philippou H, Lane D A, Morrison C E. Epidemiology of coagulation factors, inhibitors, and activation markers: the Third Glasgow MONICA survey II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol 1997; 97: 785–797
   PubMedGoogle Scholar
• Lowe G D, Lee A J, Rumley A, Price J F, Fowkes F G. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol 1997; 96: 168–173
   PubMed Web of Science ®Google Scholar
• Vayá A, Simó M, Santaolaria M, Carrasco P, Corella D. Plasma viscosity and related cardiovascular risk factors in a Spanish Mediterranean population. Thromb Res 2007; 120: 489–495
   Google Scholar
• Zawadski J K, Dunaif A. Diagnostic criteria for polycystic ovary syndrome. Polycystic ovary syndrome, A Dunaif, J R Givens, F P Haseltine, G E Merriam. Blackwell Scientific, Boston, MA 1992; 377–384
   Google Scholar
• The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004. Revised 2003 consensus on the diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 2003; 81: 19–25
   Web of Science ®Google Scholar
• Azziz R, Nestler J E, Dewailly D. Androgen excess disorders in women. Polycystic ovary syndrome and other disorders2nd ed., L C Giudice, R S Legro, R Azziz. Humana Press, Totowa, New Jersey 2006; 146–147, Chapter 13
   Google Scholar
• Mathews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment: insulin resistance and B cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419
   PubMed Web of Science ®Google Scholar
• Sarafidis P A, Lasaridis A N, Nilsson P M, Pikilidou M I, Stafilas P C, Kanaki A, Kazakos K, Yovos J, Bakris G L. Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes. J Hum Hypertens 2007; 21: 709–716
   PubMed Web of Science ®Google Scholar
• Carmina E, Lobo R A. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2004; 82: 661–665
   PubMed Web of Science ®Google Scholar
• Tai M M. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 1994; 17: 152–154
   PubMed Web of Science ®Google Scholar
• Matsuda M, DeFronzo R A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462–1470
   PubMed Web of Science ®Google Scholar
• Erdem N T, Ercan M, Akyolcu M C, Gündoğdu A S. Plasma viscosity as an early cardiovascular risk factor in hirsute women with eumenorrhea or oligomenorrhea. Fertil Steril 2003; 80: 1195–2008
   Google Scholar
• Valkenburg O, Steegers-Theunissen R P, Smedts H P, Dallinga-Thie G M, Fauser B C, Westerveld E H, Laven J S. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metab 2008; 93: 470–476
   PubMed Web of Science ®Google Scholar
• Dahlgren E, Janson P O, Johansson S, Lapidus L, Lindstedt G, Tengborn L. Hemostatic and metabolic variables in women with polycystic ovary syndrome. Fertil Steril 1994; 61: 455–460
   PubMed Web of Science ®Google Scholar
• Nasiek M, Kos-Kudla B, Ostrowska Z, Marek B, Kudla M, Siemińska L, Kajdaniuk D, Foltyn W, Zemczak A. Acute phase proteins: C-reactive protein and fibrinogen in young women with polycystic ovary syndrome. Pathophysiology 2007; 14: 23–28
   PubMedGoogle Scholar
• Nácul A P, Andrade C D, Schwarz P, de Bittencourt P I, Jr, Spritzer P M. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity. Eur J Obstet Gynecol Reprod Biol 2007; 133: 191–196
   PubMed Web of Science ®Google Scholar
• Caimi G, Sinagra D, Scarpitta A M, Lo Presti R. Plasma viscosity and insulin resistance in metabolic syndrome. Int J Obes 2001; 25: 1856–1857
   Web of Science ®Google Scholar
• Ercan M, Konukoglu D. Role of plasma viscosity and plasma homocysteine level on hyperinsulinemic obese female subjects. Clin Hemorheol Microcirc 2008; 38: 227–234
   Google Scholar
• Solá E, Vayá A, Simó M, Hernández-Mijares A, Morillas C, España F, Estellés A, Corella D. Fibrinogen, plasma viscosity and blood viscosity in obesity. Relationship with insulin resistance. Clin Hemorheol Microcirc 2007; 37: 309–318
   PubMed Web of Science ®Google Scholar
• Ercan M, Konukoglu D, Erdem Yeşim T. Association of plasma viscosity with cardiovascular risk factors in obesity: an old marker, a new insight. Clin Hemorheol Microcirc 2006; 35: 441–446
   PubMed Web of Science ®Google Scholar
• Moran L, Norman R J. Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome. Best Practice Res Clin Obstet Gynaecol 2004; 18: 719–736
   PubMedGoogle Scholar
• Paradisi G, Steinberg H O, Hempfling A, Cronin J, Hook G, Shepard M K, Baron A D. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 2001; 103: 1410–1415
   PubMed Web of Science ®Google Scholar
• Wild S, Pierpoint T, McKeigue P, Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol 2000; 52: 595–600
   PubMed Web of Science ®Google Scholar
• Kelly J C, Speirs A, Gould O W, Petrie J R, Lyall H, Connell J M. Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 742–746
   PubMed Web of Science ®Google Scholar
• Carroll S, Cook C B, Butterly R J. Plasma viscosity and its biochemical predictors: associations with lifestyle factors in healthy middle-aged men. Blood Coagul Fibrinolysis 2000; 11: 609–616
   Google Scholar
• Robert A W. Polycystic ovary syndrome: a risk for coronary artery disease. Am J Obstet Gynecol 2002; 186: 35–43
   Google Scholar
• Ernst E, Schmölzl C, Matrai A, Schramm W. Hemorheological effects of oral contraceptives. Contraception 1989; 40: 571–580
   Google Scholar